| ALDEYRA THERAPEUT.DL-,001 |
| USA |
| Gesundheit |
| US01438T1060 / A111X8 |
| 137 (Frankfurt) / ALDX (NASDAQ) |
| FRA:137, ETR:137, 137:GR, NASDAQ:ALDX |
| - |
| https://www.aldeyra.com/ |
|
Aldeyra Therapeutics Inc. is a biotechnology compa..
>Volltext.. |
| 235.22 Mio. EUR |
| 184.31 Mio. EUR |
| - |
| -38.26 Mio. EUR |
| -36.79 Mio. EUR |
| -0.61 EUR |
| 13.24 Mio. EUR |
| 50.54 Mio. EUR |
| -34.14 Mio. EUR |
| 2.64 |
| - |
| 8.51% |
| - |
| - |
| - |
| - |
| ALDEYRA |
| 16.12.25 |
|